Alberta moves to allow private diagnostic tests without a doctor's referral

Bill 29, tabled in Alberta's legislature, would let people self-refer and pay privately for certain diagnostic screening and testing without a provider's referral; officials say details on which tests and reimbursement rules will be set in upcoming regulations.

Alberta has introduced Bill 29, which would allow people to pay privately and self-refer for certain diagnostic screening and testing without a provider's referral. Primary and Preventative Health Services Minister Adriana LaGrange said the change is intended to free up the public system and support early detection. The government says reimbursement rules, which tests qualify, and other details will be set in regulations to be released later this year. The bill also includes changes to allow pharmacies to keep a limited supply of certain addiction treatment medications for urgent access in some communities. What officials announced: - Bill 29 was tabled in the legislature and would permit self-referred private purchases of preventive diagnostic tests if passed. - Minister Adriana LaGrange said the aim is to add capacity, support early detection and protect the public system, and that eligible tests and criteria will be determined in regulations. - The government said it would act as the "payer of last resort," with private insurers to be billed first for those who have coverage. - The legislation would allow community pharmacies to hold a limited supply of certain low‑risk opioid agonist medications to improve timely access in rural and Indigenous communities. Summary: If passed, the bill would enable private-payment self-referral for certain diagnostic tests while the public system continues to cover tests ordered by health providers. Officials say detailed rules, the list of eligible tests and reimbursement arrangements will be set in upcoming regulations expected later this year. Opposition figures have raised concerns about potential effects on equity and continuity of care. Undetermined at this time.